Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells

Published:2022-09-22 Issue:3 Volume:44 Page:661-669
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Chen Yi-fan,Liu Run-zhi,Ying Wen-wen,Yang Yue-ning,Xiang Sen-feng,Shao Xue-jing,Cao Ji,Zhang Yan-qi,Yang Bo,He Qiao-jun,Ying Mei-dan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-022-00992-6.pdf

Reference37 articles.

1. Watson IR, Irwin MS, Ohh M. NEDD8 pathways in cancer, Sine Quibus Non. Cancer Cell. 2011;19:168–76.

2. Chen P, Hu T, Liang YP, Li P, Chen XY, Zhang JY, et al. Neddylation inhibition activates the extrinsic apoptosis pathway through ATF4-CHOP-DR5 axis in human esophageal cancer cells. Clin Cancer Res. 2016;22:4145–57.

3. Li LH, Wang MS, Yu GY, Chen P, Li H, Wei DP, et al. Overactivated neddylation pathway as a therapeutic target in lung cancer. J Natl Cancer I. 2014;106:dju083.

4. Xie P, Yang JP, Cao Y, Peng LX, Zheng LS, Sun R, et al. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target. Cell Death Dis. 2017;8:e2834.

5. Barbier-Torres L, Delgado TC, Garcia-Rodriguez JL, Zubiete-Franco I, Fernandez-Ramos D, Buque X, et al. Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer. Oncotarget. 2015;6:2509–23.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel small molecules targeting the USP21/JAK2/STAT3 axis for the treatment of triple-negative breast cancer;European Journal of Medicinal Chemistry;2024-07

2. The Double-Edged Effects of MLN4924: Rethinking Anti-Cancer Drugs Targeting the Neddylation Pathway;Biomolecules;2024-06-21

3. Protein neddylation and its role in health and diseases;Signal Transduction and Targeted Therapy;2024-04-05

4. The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer;Journal of Cancer Research and Clinical Oncology;2024-03-23

5. Micafungin: A promising inhibitor of UBE2M in cancer cell growth suppression;European Journal of Medicinal Chemistry;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3